- Home
- UONEK vs CRIS Comparison
UONEK vs CRIS Comparison
Compare UONEK & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- CRIS
- Stock Information
- Founded
- UONEK 1980
- CRIS 2000
- Country
- UONEK United States
- CRIS United States
- Employees
- UONEK N/A
- CRIS N/A
- Industry
- UONEK Broadcasting
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UONEK Consumer Discretionary
- CRIS Health Care
- Exchange
- UONEK Nasdaq
- CRIS Nasdaq
- Market Cap
- UONEK 22.6M
- CRIS 13.5M
- IPO Year
- UONEK N/A
- CRIS 2000
- Fundamental
- Price
- UONEK $0.47
- CRIS $1.96
- Analyst Decision
- UONEK
- CRIS Strong Buy
- Analyst Count
- UONEK 0
- CRIS 3
- Target Price
- UONEK N/A
- CRIS $21.00
- AVG Volume (30 Days)
- UONEK 41.1K
- CRIS 99.1K
- Earning Date
- UONEK 05-13-2025
- CRIS 05-06-2025
- Dividend Yield
- UONEK N/A
- CRIS N/A
- EPS Growth
- UONEK N/A
- CRIS N/A
- EPS
- UONEK N/A
- CRIS N/A
- Revenue
- UONEK $449,674,000.00
- CRIS $11,202,000.00
- Revenue This Year
- UONEK N/A
- CRIS $4.67
- Revenue Next Year
- UONEK N/A
- CRIS $9.77
- P/E Ratio
- UONEK N/A
- CRIS N/A
- Revenue Growth
- UONEK N/A
- CRIS 14.17
- 52 Week Low
- UONEK $0.44
- CRIS $1.02
- 52 Week High
- UONEK $2.07
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- UONEK 39.01
- CRIS 50.58
- Support Level
- UONEK $0.44
- CRIS $1.85
- Resistance Level
- UONEK $0.49
- CRIS $2.25
- Average True Range (ATR)
- UONEK 0.03
- CRIS 0.27
- MACD
- UONEK 0.00
- CRIS 0.04
- Stochastic Oscillator
- UONEK 36.67
- CRIS 41.73
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.